Sbc Medical Group logo

Sbc Medical Group(NASDAQ) SBC

Market Cap$517.32MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2022)-50%
5 YearN/A
1 Year+18%
1 Month+24%
Premium Feature
Moneyball Superscore
50/100
$4.82
-4.18%
-0.21Today
Sbc Medical Group last closing stock price
MetricPriceDate
Last closeUSD 5.032026-09-28
Sbc Medical Group stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-2.14%USD 5.142026-09-21
1 month+24.2%USD 4.052026-08-28
3 month+63.31%USD 3.082026-06-30
Year to date+16.71%USD 4.312025-12-31
1 year+17.8%USD 4.272025-09-26
3 year-52.88%USD 10.682023-09-29
Since inception-49.5%USD 9.962022-09-26

Sbc Medical Group Financials at a Glance

Market Cap

$517.32MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$175.17M

Net Income (TTM)

$49.03M

EPS (TTM)

$0.48

P/E Ratio

10.53

Dividend

$0.00

Beta (Volatility)

0.15 (Low)

Price

$4.82

Volume

46,574.495

Open

$5.01

Previous Close

$5.03

Daily Range

$4.80 - $5.02

52-Week Range

$2.78 - $5.29

Estimated Earnings Date

Nov 12, 2026

SBC News

SBC: Motley Fool Moneyball Superscore

50

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Sbc Medical Group

SBC Medical Group Holdings Incorporated helps cosmetic clinics manage daily work. It provides marketing, staff training, and equipment to clinic owners. These tools let doctors focus on treating their patients.

What SBC Provides

  • Management Services: Administrative support including marketing, recruitment, and booking systems; generated $24.8 million for the six-month period ended June 30, 2026.
  • Procurement: Resale of medical equipment and supplies to franchisee clinics; accounted for $25.7 million for the six-month period ended June 30, 2026.
  • Franchising: Rights to use the Shonan Beauty Clinic brand and business model; contributed $18.6 million for the six-month period ended June 30, 2026.
  • Rental Services: Leasing of specialized medical gear like laser hair removal machines; added $7.3 million for the six-month period ended June 30, 2026.
  • Waqoo Segment: Medical support services and direct-to-consumer product sales; represented $4.5 million for the six-month period ended June 30, 2026.

Growing the Brand

  • Consummated a business combination in Sept. 2024 to become a publicly traded company.
  • Acquired Aesthetic Healthcare Holdings in Nov. 2024 to expand its medical aesthetic presence in Singapore.
  • Purchased a controlling interest in Waqoo in Dec. 2025 to add direct-to-consumer sales and support.
  • Renewed business agreements in June 2026 that are expected to increase annual revenue by $15 million.

A Unique Business Model

SBC operates as a medical service corporation, which is a Japanese legal entity that manages medical clinics. The company handles a wide range of needs for its franchisees, including real estate for staff housing and custom software for remote medical consultations.

A Look at the Numbers

  • Total revenue reached $92.2 million for the six-month period ended June 30, 2026, up 1.7% year over year.
  • Net income was $22.0 million for the six-month period ended June 30, 2026, down 8.2% year over year.
  • Cash and cash equivalents grew to $184.3 million as of June 30, 2026.
  • Market capitalization was $428.8 million in the first quarter of 2026, up 30.1% year over year.

Bottom Line

SBC has transitioned from a regional management firm into a multi-segment international health services provider. Its shift toward direct-to-consumer products and updated service fees reflects a strategy of diversifying its revenue across global markets.

AI Generated • Aug 13, 2026

Industry

Healthcare Providers and Services

Employees

863

CEO

Yoshiyuki Aikawa, PhD

Headquarters

Irvine, CA 92618, US

SBC Financials

Key Financial Metrics (TTM)

Gross Margin

71.27%

Operating Margin

37.34%

Net Income Margin

27.99%

Return on Equity

19.31%

Return on Capital

22.50%

Return on Assets

12.06%

Earnings Yield

9.50%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$517.32MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

102.85M

Volume

46.57K

Avg. Volume

152.85K

Financials (TTM)

Gross Profit

$124.84M

Operating Income

$65.41M

EBITDA

$76.46M

Operating Cash Flow

$77.07M

Capital Expenditure

-$2.12M

Free Cash Flow

$74.96M

Cash & ST Invst.

$184.62M

Total Debt

$48.23M

Sbc Medical Group Performance Analysis

Sbc Medical Group annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 0N/A
20232023-12-31USD 193,542,423N/A
20242024-12-31USD 205,415,5426.1%
20252025-12-31USD 173,607,489-15.5%
Sbc Medical Group sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30-0.0%
Q42025-12-31-8.7%
Q12026-03-318.8%
Q22026-06-3014.2%
Sbc Medical Group annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD 0.04N/A
20232023-12-31USD 0.421039.0%
20242024-12-31USD 0.4815.5%
20252025-12-31USD 0.502.5%
Sbc Medical Group sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30404.2%
Q42025-12-3116.7%
Q12026-03-31-21.4%
Q22026-06-30-9.1%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$49.19M

+13.4%

Gross Profit

$35.98M

+19.9%

Gross Margin

73.14%

N/A

Market Cap

$517.32MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$599.44K

N/A

Employees

863

N/A

Net Income

$10.69M

+335.0%

EBITDA

$18.25M

+28.3%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$184.62M

+20.9%

Total Debt

$48.23M

+210.6%

Accounts Receivable

$64.55M

-11.8%

Inventory

$2.98M

+74.7%

Long Term Debt

$30.91M

+267.8%

Short Term Debt

$17.32M

+143.0%

Return on Assets

12.06%

N/A

Return on Invested Capital

19.93%

N/A

Free Cash Flow

$22.04M

+349.1%

Operating Cash Flow

$22.51M

+369.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
PANLPangaea Logistics Solutions, Ltd.
$8.05+0.44%
WNCWabash National Corporation
$12.38-2.13%
BBCPConcrete Pumping Holdings, Inc.
$9.60-3.03%
LXFRLuxfer Holdings PLC
$17.28-0.03%

Trending Stocks

Symbol / CompanyPricePrice Chg
HYGiShares Trust - iShares iBoxx $ High Yieldorate Bond ETF
$77.19-0.46%
SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF
$33.18-3.65%
INTCIntel
$116.30+0.23%
NVDANvidia
$229.41+0.24%

Questions About SBC

What is the current price of Sbc Medical Group?

Sbc Medical Group is trading at $4.82 per share.

What is the 52-week range for Sbc Medical Group?

Over the past 52 weeks, Sbc Medical Group has traded between $2.78 and $5.29.

How much debt does Sbc Medical Group have?

As of the most recent reporting period, Sbc Medical Group reported total debt of $48.23M.

How much cash does Sbc Medical Group have on hand?

Sbc Medical Group reported $184.31M in cash and cash equivalents in its most recent financial results.

What is Sbc Medical Group’s dividend yield?

Sbc Medical Group does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.